Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 53
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02574598 | MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients | ||
| NCT02531412 | Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients | ||
| NCT04019808 | Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population | ||
| NCT01542437 | Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer | ||
| NCT04562818 | Results From a Mexican Acute Promyelocytic Leukemia. | ||
| NCT03275194 | HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy | ||
| NCT05445791 | Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations | ||
| NCT02758314 | Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients | ||
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | ||
| NCT01869023 | Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma | ||
| NCT01880515 | Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib) | ||
| NCT04311060 | Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study. | ||
| NCT04338867 | Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients | ||
| NCT01566799 | Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer | ||
| NCT06881940 | Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab | ||
| NCT01087476 | Double-blind-randomized,Placebo Controlled Trial for Chemotherapy-associated Oral Mucositis Using Doxycycline Hyclate | ||
| NCT04015466 | Advanced GC Multi-omic Characterization in EU and CELAC Populations | ||
| NCT05315596 | Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery | ||
| NCT01540045 | Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer | ||
| NCT06883409 | Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer | ||
| NCT07524803 | Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM) | ||
| NCT04748523 | Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia | ||
| NCT01894633 | Study of Whole-brain Irradiation With Chloroquine for Brain Metastases | ||
| NCT04407468 | Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 | ||
| NCT01631565 | Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care | ||
| NCT05267496 | Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery | ||
| NCT01015534 | Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment | ||
| NCT02502240 | ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP) | ||
| NCT00437853 | Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer | ||
| NCT02095925 | Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism | ||
| NCT02978521 | Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients | ||
| NCT03803787 | Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients | ||
| NCT01662635 | Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) | ||
| NCT02805530 | Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma | ||
| NCT01603849 | Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis | ||
| NCT06181812 | Pathogenic Variants in Genes Associated With Lung Adenocarcinoma | ||
| NCT02734069 | Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC | ||
| NCT00429065 | Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. | ||
| NCT06477302 | Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer | ||
| NCT01580579 | Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation | ||
| NCT06535451 | Lung Cancer Screening Program in Mexico | ||
| NCT03071705 | Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma | ||
| NCT04388410 | Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 | ||
| NCT06238882 | Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. | ||
| NCT05852990 | Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC | ||
| NCT02802540 | Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients | ||
| NCT06422533 | Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients | ||
| NCT03957031 | Gastric Cancer Risk Factors Associated With EU and CELAC Populations | ||
| NCT06090747 | Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. | ||
| NCT03606369 | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. |
